the flipside to this watershed announcement was that it represented Biomira electing NOT to take up worldwide rights to CVac . . . . which they were entitled to . . .. . . but would have required that they fund the Phase III trial, and pay PRR a market rate royalty (presumably high single figures).
The spin from PRR was that Biomira had changed direction and was not interested in CVac any more. . . .. but still, Biomira was a bigger international company that said "NO" TO CVAC.
Maybe the path is a bit easier now thanks to Dendreon etc., but let's not see only positives, hey. . . .
the flipside to this watershed announcement was that it...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $598.3M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.0¢ | 39.5¢ | $890.1K | 2.163M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 127863 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 30850 | 2 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |